Linda Cotter

Learn More
BACKGROUND Several trials support the usefulness of disease management (DM) for improving clinical outcomes in heart failure (HF). Most of these studies are limited by small sample size; absence of concurrent, randomized controls; limited follow-up; restriction to urban academic centers; and low baseline use of effective medications. METHODS AND RESULTS(More)
Methods The introduction of a sequence of interventions targeted at reducing MRSA bacteraemias by a newly expended infection control team, after analysis of existing polices and procedures. The use of MRSA antimicrobials in the Trust’s formulary was optimised. Teicoplanin was substituted with daptomycin in medical and surgical wards. In Intensive Care(More)
Introduction. Heart failure is a chronic condition representing a major and increasing cause of death and disability currently afflicting over four million Americans. A number of recent studies have shown that careful attention to the early signs of decompensation and appropriate care can decrease hospitalizations and improve quality of life. Approaches(More)
  • 1